Uncategorized
VIDEO: Sustained DME treatment stabilizes central subfield thickness
VANCOUVER, British Columbia — Christopher D. Riemann, MD, of Cincinnati Eye Institute, discusses his research regarding central subfield thickness in diabetic macular edema patients receiving Iluvien (fluocinolone acetonide intravitreal implant 0.19 mg, Alimera Sciences). Continuous treatment has shown a stabilization over time of OCT central subfield thickness, he said.